# OnCo record idea-late-recurrence-interception (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-late-recurrence-interception/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-late-recurrence-interception" ;
  schema:name "Intercepting late recurrence with ctDNA surveillance and oral SERDs"@en ;
  schema:description "Half of hormone-positive recurrences happen after year five. Blood tests during long-term follow-up could find them early and an oral SERD might stop them."@en ;
  schema:url <https://onco.cc/ideas/idea-late-recurrence-interception/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-022-02115-4> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/camizestrant/>, <https://onco.cc/drugs/giredestrant/>, <https://onco.cc/drugs/signatera/> ;
  onco:terms <https://onco.cc/terms/late-recurrence/>, <https://onco.cc/terms/mrd/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct04214288-lancet-oncol-2024/> .